Solana (SOL) has demonstrated impressive resilience, maintaining strength while most major cryptocurrencies declined. On August 29, SOL surged above $210 and peaked at $218 before briefly falling below $200. Technical readings imply that Solana’s downturn is a corrective move instead of a negative one. Analysts note that the pullback can form a strong foundation for […]Solana (SOL) has demonstrated impressive resilience, maintaining strength while most major cryptocurrencies declined. On August 29, SOL surged above $210 and peaked at $218 before briefly falling below $200. Technical readings imply that Solana’s downturn is a corrective move instead of a negative one. Analysts note that the pullback can form a strong foundation for […]

Solana Surges Despite Pullback: Breakout Around $240 Level

solana
  • Solana climbed higher than $210 and briefly traded at $218 despite larger market declines.
  • SOL price at $197.78 with a market capitalization of $106.98 billion, supported at $200 and resisted at $215.
  • Analysts regard correction as consolidation and anticipate a possible breakout towards $240 if support at $200 holds.

Solana (SOL) has demonstrated impressive resilience, maintaining strength while most major cryptocurrencies declined. On August 29, SOL surged above $210 and peaked at $218 before briefly falling below $200.

Technical readings imply that Solana’s downturn is a corrective move instead of a negative one. Analysts note that the pullback can form a strong foundation for yet another breakout. Despite broader market uncertainty, SOL’s movement indicates a consolidating phase instead of weakness and is poised to lead the charge once favorable circumstances come together to favor an upside move.

Solana currently exchanges at about $197.09, which is down 3.56% on the day, with a market cap varies at $106.98 billion. Although day figures appear discouraging, Solana’s broader performance continues to highlight relative strength compared to peers, reinforcing confidence among long-term investors.

image 22Source: TradingView

Also Read | Solana Price Prediction: Will $205 Hold or Spark a Major Breakdown?

Solana Price Faces Key $200 Support

According to a recent post, $SOL emerged as the most mentioned ticker in the past hour, signaling heightened market attention. Solana is currently within a bearish trend and is trading below the 5, 10, and 20-hour moving averages. Analysts note a strong support at roughly $200 and the resistance at roughly $215.

image 23Source: X

Technicals are weak, and the RSI is moving downwards, and the MACD is showing bearish momentum, indicating possible further declines if it fails at support. Traders are observing these levels closely for potential market responses.

SOL Momentum Could Reach $240

Analyst RLinda emphasized that the correction is not a reversal. It is instead consolidation in a healthy pattern. He expects a liquidity test between $202.5 and $195.3. Preserving the $200 support zone intact may keep Solana on its positive trajectory despite temporary volatility and confusing trading action.

image 24Source: TradingView

In case the support around $200 is maintained, SOL may go up to $215 again and later surpass $220. Analyst RLinda said that the small drop is similar to a pause in the trend, not a turnaround. 

If $200 zone remains intact, Solana could likely take the positive trend back with a move toward $240 becoming possible within the next several days. Although the correction period is not yet over, the fact that SOL has managed to stay strong and has attracted investors’ attention to lead the next market uptrend once the ongoing correction concludes.

Also Read | Injective (INJ) Price Analysis: Will $12 Support Hold or Drop Toward $10?

Market Opportunity
Solana Logo
Solana Price(SOL)
$141.74
$141.74$141.74
-1.22%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23